This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.


Novo Nordisk A/S

Drug Names(s): insulin detemir, NN304

Description: Levemir is a long-acting basal insulin analog that is administered once or twice daily. It has a relatively flat action profile. Basal insulins provide insulin throughout the day and night, helping to control blood sugar level between meals and during sleep.

Levemir News

Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug